Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile

S&P 500 Healthcare stocks: today's ranking and data

The S&P 500 has 59 companies in Healthcare today. It accounts for 10.2% of the market value of the index companies. Its median P/E is 32.8, against 23.5 for the index as a whole.

What Healthcare is and what drives its earnings

What it includes. Drug makers and biotech, medical device and supply makers, health insurers and managed-care companies, drug distributors, hospitals and clinics, and diagnostics, lab and research-tools companies.

What drives its earnings. For drug makers, the patent cycle (when a drug's patent expires, generics arrive and its sales drop sharply), clinical trials and FDA approvals. Across the sector, drug pricing and what Medicare and Medicaid reimburse. For insurers, the gap between the premiums they collect and the medical costs they pay. And underneath it all, an aging population.

How it behaves. It is considered defensive because demand for health care depends little on the economic cycle, but it carries a risk of its own, regulatory and political: a change in drug pricing or public reimbursement hits many companies in the sector at once.

The classification is the one used by this site's data provider, similar to but not the same as GICS, S&P's standard: this sector roughly matches "Health Care". Counts may therefore differ from other sources.

All 59 stocks in the sector, by today's multi-factor rank

The rank is the order produced by a quantitative model on data as of Nov 13, 2026: the average of four factors (momentum, value, quality and growth) computed from public data, against the 463 index companies that score. It is a calculation, not a recommendation to buy or sell: it knows nothing about anyone's situation, horizon or risk, and the returns of portfolios built with it are simulated. How it is computed: see the methodology.

In sectorIndex rankCompanyP/EMarket cap
117 of 463CVS CVS Health10.4$114.32B
223 of 463CNC Centene24.4$35.28B
324 of 463HUM Humana43.7$54.05B
445 of 463ELV Elevance Health18.3$92.84B
549 of 463LLY Eli Lilly46.9$1.29T
664 of 463VTRS Viatris—$23.87B
767 of 463ABBV AbbVie50.8$521.50B
896 of 463DXCM DexCom32.8$31.08B
9120 of 463CI Cigna13.1$78.26B
10125 of 463RVTY Revvity68.6$17.24B
11135 of 463WST West Pharmaceutical Services46.7$29.01B
12140 of 463JNJ Johnson & Johnson43.4$687.89B
13144 of 463CAH Cardinal Health36.4$64.97B
14146 of 463HSIC Henry Schein23.6$9.53B
15153 of 463UNH UnitedHealth23.3$365.09B
16157 of 463MCK McKesson28.4$127.33B
17159 of 463DGX Quest Diagnostics25.9$28.56B
18163 of 463BMY Bristol-Myers Squibb14.1$129.66B
19171 of 463REGN Regeneron Pharmaceuticals21.1$98.84B
20172 of 463MRK Merck150.8$364.26B
21175 of 463UHS Universal Health Services8.1$11.19B
22179 of 463VRTX Vertex Pharmaceuticals34.7$136.56B
23186 of 463BIIB Biogen109.2$37.46B
24190 of 463AMGN Amgen27.0$251.89B
25192 of 463TECH Bio-Techne66.8$11.44B
26198 of 463COR Cencora20.0$68.51B
27207 of 463BAX Baxter International—$13.35B
28219 of 463LH Labcorp30.4$30.08B
29221 of 463ZBH Zimmer Biomet26.1$19.53B
30248 of 463BDX Becton, Dickinson43.1$59.39B
31249 of 463PFE Pfizer41.3$164.67B
32257 of 463A Agilent Technologies34.3$49.05B
33258 of 463VEEV Veeva Systems49.4$48.82B
34265 of 463EW Edwards Lifesciences60.5$61.61B
35268 of 463TMO Thermo Fisher Scientific36.9$259.44B
36269 of 463ALGN Align Technology24.5$11.86B
37270 of 463CRL Charles River Laboratories International348.4$16.19B
38276 of 463RMD ResMed21.8$33.69B
39293 of 463MDT Medtronic25.3$131.57B
40295 of 463WAT Waters197.5$90.45B
41296 of 463IDXX IDEXX Laboratories47.5$55.48B
42308 of 463DHR Danaher38.1$163.94B
43316 of 463COO Cooper Companies21.5$11.91B
44349 of 463GEHC GE HealthCare Technologies17.5$37.54B
45360 of 463IQV IQVIA32.3$43.69B
46361 of 463MTD Mettler-Toledo International37.7$34.59B
47391 of 463ISRG Intuitive Surgical53.7$153.77B
48392 of 463INCY Incyte64.3$24.66B
49405 of 463SYK Stryker33.0$117.88B
50406 of 463PODD Insulet24.9$10.58B
51409 of 463SOLV Solventum101.2$15.14B
52413 of 463STE STERIS31.4$25.67B
53419 of 463ZTS Zoetis14.1$34.06B
54422 of 463GILD Gilead Sciences—$208.48B
55442 of 463BSX Boston Scientific18.8$64.27B
56449 of 463ABT Abbott Laboratories40.3$187.95B
—not scored todayDVA DaVita12.9$10.98B
—not scored todayHCA HCA Healthcare16.6$104.25B
—not scored todayMRNA Moderna—$90.38B

"—" under P/E: no positive P/E (negative trailing earnings or missing at the source). 3 stocks do not get a multi-factor score today because a factor is missing; they go last, alphabetically. The full S&P 500 ranking →

Healthcare P/E against the index

Median P/ECompanies with a positive P/E
Healthcare32.855 of 59
S&P 50023.5475 of 500

The median is the company in the middle: a few firms with near-zero earnings and huge P/Es do not move it, which is what happens to the average. Loss-making companies have no P/E and are left out.

Guide: P/E ratio explained · all guides

The 10 largest in the sector by market cap

#CompanyMarket capWeight in sectorRank today
1LLY Eli Lilly$1.29T18.2%49
2JNJ Johnson & Johnson$687.89B9.7%140
3ABBV AbbVie$521.50B7.4%67
4UNH UnitedHealth$365.09B5.2%153
5MRK Merck$364.26B5.2%172
6TMO Thermo Fisher Scientific$259.44B3.7%268
7AMGN Amgen$251.89B3.6%190
8GILD Gilead Sciences$208.48B3.0%422
9ABT Abbott Laboratories$187.95B2.7%449
10PFE Pfizer$164.67B2.3%249

Total market value (price times shares outstanding), without the float adjustment S&P applies: the weight is indicative. Companies with two share classes count once.

Insider buying and selling in the last 30 days

From Oct 14, 2026 to Nov 13, 2026, 1 open-market purchase ($2.0M) and 86 sales ($527.7M), filed on SEC Form 4 by directors, officers and 10% owners of 33 companies in the sector. Counted by trade date; grants, option exercises and transfers between the same insider's accounts are left out.

CompanyBuysAmountSalesAmount
SYK Stryker0—1$178.9M
DVA DaVita0—1$69.0M
REGN Regeneron Pharmaceuticals0—9$49.6M
INCY Incyte0—3$28.8M
IDXX IDEXX Laboratories0—4$27.4M
GILD Gilead Sciences0—7$26.5M
ISRG Intuitive Surgical0—13$19.7M
HCA HCA Healthcare0—4$18.3M
MRNA Moderna0—2$17.0M
DHR Danaher0—4$13.4M
ABBV AbbVie0—1$11.9M
CRL Charles River Laboratories International0—2$9.2M
DGX Quest Diagnostics0—3$8.8M
EW Edwards Lifesciences0—3$7.5M
LLY Eli Lilly0—1$7.0M
VRTX Vertex Pharmaceuticals0—1$6.3M
MDT Medtronic0—2$5.8M
ELV Elevance Health0—2$5.2M
STE STERIS0—2$2.7M
HUM Humana0—2$2.6M
MCK McKesson0—3$2.1M
CVS CVS Health1$2.0M0—
TMO Thermo Fisher Scientific0—1$2.0M
VEEV Veeva Systems0—1$1.6M
RMD ResMed0—2$1.3M
LH Labcorp0—3$1.2M
IQV IQVIA0—1$1.2M
MTD Mettler-Toledo International0—1$754k
BDX Becton, Dickinson0—2$644k
ABT Abbott Laboratories0—1$406k
DXCM DexCom0—2$347k
COR Cencora0—1$326k
BMY Bristol-Myers Squibb0—1$241k

All S&P 500 insider buying →

Upcoming earnings dates

Dates announced by the companies themselves, from Nasdaq's public calendar (between Nov 13, 2026 and Dec 17, 2026). They are announcements, not measured dates: each company's SEC history is on its earnings page.

DateCompanyWhen
Nov 19, 2026VEEV Veeva Systemsno time announced
Nov 23, 2026A Agilent Technologiesafter the close
Nov 24, 2026MDT Medtronicbefore the open
Dec 3, 2026COO Cooper Companiesafter the close

Who reports this week across the S&P 500 →

The other S&P 500 sectors

All 11 sectors compared →

Dividend yields in Healthcare and across the S&P 500 →

Sources: sector classification, market cap and P/E from the market-data provider (Yahoo Finance), as of the latest close downloaded; Quant500 multi-factor ranking of Nov 13, 2026; SEC Form 4 (EDGAR); Nasdaq public calendar. P/E is trailing twelve months and the median is taken per company, not per share class. Not investment advice.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity